64 results
8-K
EX-99.2
ADVM
Adverum Biotechnologies Inc
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
, within thirty (30) business days of the Effective Date (as defined in the Stipulation), Defendants shall implement the following Corporate Governance Reforms
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
on Plaintiff’s demand for corporate governance reforms at the Company (the “Reforms”);
WHEREAS, after multiple rounds of arm’s-length negotiations … : Jan 24 2024 08:26PM EST
Transaction ID 71868895
Case No. 2022-1062-MTZ
Exhibit A
CORPORATE GOVERNANCE REFORMS
Within thirty (30) business days
8-K
EX-10.1
ADVM
Adverum Biotechnologies Inc
5 Feb 24
Entry into a Material Definitive Agreement
5:03pm
its review of the listing of the Shares, it will be in compliance with all applicable corporate governance requirements set forth in the Nasdaq’s
8-K/A
15az1nb5ywx 0rp8k
4 Dec 23
Departure of Directors or Certain Officers
4:09pm
8-K
az0iu9kuhn 9m
6 Nov 23
Departure of Directors or Certain Officers
4:10pm
8-K
b91mw oaia1i9ax
19 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
EX-1.1
jtw49q0mqsr 3hgw47z8
11 May 23
Other Events
4:45pm
PRE 14A
jt2v7ln0gdx3c w93
14 Apr 23
Preliminary proxy
6:03am
8-K
yyt8ca4e7
17 Mar 22
Departure of Directors or Certain Officers
4:36pm
DEFC14A
1rc3m
15 Apr 21
Proxy in contested solicitation
4:34pm
DEFA14A
h3rf88jtp6 hkpnfu6o
15 Apr 21
Additional proxy soliciting materials
8:59am
DEFC14A
2xdy xgouvaq
15 Apr 21
Proxy in contested solicitation
6:03am